BFSG LLC
DGX icon

BFSG LLC’s Quest Diagnostics DGX Stock Holding History

BFSG LLC’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.63K Buy
+7
New +$1.62K ﹤0.01% 780
2022
Q3 		– Sell
-1,700
Closed -$226K – 179
2022
Q2 		$226K Buy
+1,700
New +$232K 0.04% 184

Other funds holding DGX

Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Davis Selected Advisers
Davis Selected Advisers Tucson, Arizona $23.2B AUM 18.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

BFSG LLC's DGX Position: Q3 2026 in Review

BFSG LLC opened a new position in Quest Diagnostics (DGX) in Q3 2026: 7 shares worth $1.63K. The stake represents ﹤0.01% of the portfolio and ranks #780 among its holdings. This is a return to the name: BFSG LLC previously reported a position in DGX as recently as Q2 2022.

BFSG LLC first reported a position in DGX in Q2 2022 and has held it in 2 quarters since. The position peaked at $226K in Q2 2022. 722 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • BFSG LLC held 7 shares of Quest Diagnostics worth $1.63K as of Q3 2026.
  • Quest Diagnostics was a new BFSG LLC position in Q3 2026.
  • Quest Diagnostics made up ﹤0.01% of BFSG LLC's portfolio in Q3 2026, its #780 holding.
  • BFSG LLC first reported a position in Quest Diagnostics in Q2 2022 and has held it in 2 quarters since.
  • BFSG LLC's Quest Diagnostics position peaked at $226K in Q2 2022.
  • 722 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on BFSG LLC's 13F filing for Q3 2026, filed 30 Oct 2026.